Your browser doesn't support javascript.
loading
A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required.
Abujarour, Ramzey; Dinella, Jason; Pribadi, Mochtar; Fong, Lauren K; Denholtz, Matthew; Gutierrez, Alma; Haynes, Matt; Mahmood, Enaaya; Lee, Tom T; Ding, Sheng; Valamehr, Bahram.
Afiliação
  • Abujarour R; Fate Therapeutics, San Diego, CA 92121, USA.
  • Dinella J; Fate Therapeutics, San Diego, CA 92121, USA.
  • Pribadi M; Fate Therapeutics, San Diego, CA 92121, USA.
  • Fong LK; Fate Therapeutics, San Diego, CA 92121, USA.
  • Denholtz M; Fate Therapeutics, San Diego, CA 92121, USA.
  • Gutierrez A; Fate Therapeutics, San Diego, CA 92121, USA.
  • Haynes M; Fate Therapeutics, San Diego, CA 92121, USA.
  • Mahmood E; Fate Therapeutics, San Diego, CA 92121, USA.
  • Lee TT; Fate Therapeutics, San Diego, CA 92121, USA.
  • Ding S; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
  • Valamehr B; Fate Therapeutics, San Diego, CA 92121, USA.
Future Sci OA ; 10(1): FSO964, 2024.
Article em En | MEDLINE | ID: mdl-38817352
ABSTRACT

Aim:

We explored the generation of human induced pluripotent stem cells (iPSCs) solely through the transcriptional activation of endogenous genes by CRISPR activation (CRISPRa).

Methods:

Minimal number of human-specific guide RNAs targeting a limited set of loci were used with a unique cocktail of small molecules (CRISPRa-SM).

Results:

iPSC clones were efficiently generated by CRISPRa-SM, expressed general and naive iPSC markers and clustered with high-quality iPSCs generated using conventional reprogramming methods. iPSCs showed genomic stability and robust pluripotent potential as assessed by in vitro and in vivo.

Conclusion:

CRISPRa-SM-generated human iPSCs by direct and multiplexed loci activation facilitating a unique and potentially safer cellular reprogramming process to aid potential applications in cellular therapy and regenerative medicine.
Combined chemical and CRISPRa-mediated approach leads to efficient generation of human iPSCs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Future Sci OA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Future Sci OA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos